Navigation Links
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Date:10/19/2009

EMERYVILLE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE-Amex: NBY), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral, and fungal infections, today announced that the company has named Mark Anderson, Ph.D. as chief scientific officer, a new position for the company.

"We are adding Mark to our team at a critical time as our partnerships with Alcon and Galderma gather significant clinical momentum and our already robust internal pipeline continues to expand," said Ron Najafi, Ph.D., chairman and chief executive officer of NovaBay. "Mark's expertise in the field of infectious diseases and proven track record of clinical success, combined with his demonstrated leadership capabilities, make him an excellent addition to our team. We look forward to his contributions as his experience adds great depth and a new dimension to our management team in this strategically important area to the business."

Dr. Anderson's credentials include over 17 years of successfully leading research and development programs. He holds numerous patents, patent applications and publications to his credit. Prior to joining NovaBay, he has held senior positions at Myriad Genetics, Elitra Pharmaceuticals, Pfizer-Agouron and Ligand-Glycomed. Dr. Anderson holds a doctorate from Purdue University, and completed postdoctoral studies in chemical biology at Harvard University.

"It is an honor to be working with this accomplished scientific team," commented Dr. Anderson. "NovaBay's Aganocide® compounds offer the potential to significantly impact the widespread and growing problem of drug resistance to bacterial, viral and fungal infections. I look forward to beginning my work
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections
2. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
3. Alcon Commences Phase 2 Clinical Trial of NovaBays NVC-422 for Viral Conjunctivitis
4. NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds
5. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
6. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
7. EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimers Disease Patient
8. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
9. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
10. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
11. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 The Physician-Patient ... release on July 28, 2015, "Surviving Your Hospital ... Fundraising for Patient Safety." A sentence ... should read: "PPAHS is a member ... on Opioids. For more information on the National Coalition ...
(Date:7/31/2015)... Quietly, sedately, Morocco,s pharmaceutical sector ... pharmaceutical industry is strong, with a well-developed base of ... standards. One place where the quality of ... Morocco has quietly become the second largest African exporter ... . Indeed, Moroccan pharma companies have been making inroads ...
(Date:7/31/2015)... 2015  Xencor, Inc. (NASDAQ: XNCR ), a ... treatment of autoimmune diseases, asthma and allergic diseases, and ... Hata to its board of directors. ... development is a tremendous asset to our board," said ... officer of Xencor. "Xencor faces a range of opportunities ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... , BERKELEY HEIGHTS, N.J. , June 15 Access ... president and chief executive officer (CEO). Since mid-2009, Access was under the ... served in addition to his responsibilities as chief financial officer (CFO). ... "I am humbled and ...
... June 15 Eleme Medical Inc., a ... all areas of body shaping, announced today that CEO ... recipient of a Leadership Award from non-profit group Women ... scientists and engineers to develop an entrepreneurial mindset and ...
Cached Medicine Technology:New President and Chief Executive Officer Named at Access Communications, LLC 2New President and Chief Executive Officer Named at Access Communications, LLC 3Eleme Medical's President and CEO Nancy Briefs Honored with Leadership Award from Women Entrepreneurs in Science and Technology 2
(Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a ... Those looking to catch a new and refreshing show on Broadway, look no further ... achievements including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel ...
(Date:7/31/2015)... New York (PRWEB) , ... ... ... trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now ... 28th, 2015 was well received with a 94% approval rating from the ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Transfinder, a software ... , Total sales were up 16 percent year-over-year for the first six months ended ... Civitella said he expected Transfinder to beat last year’s record-revenue mark of $10.4 million. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Mullin/Ashley Associates , ... the 2015 Aster Awards national competition for a marketing communications campaign created for ... surrounding communities in Coastal Maryland and Southern Delaware. , A Bronze Award was ...
Breaking Medicine News(10 mins):Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2
... new test that screens babies for the presence of a ... on Tuesday. Group B streptococcus// is a common infection that ... pneumonia, meningitis, neurological damage or even death. ,Although ... current screening methods can leave some babies at risk for ...
... the mind are really mysterious, however these have inspired ... of the brain affected by the// personality disorder schizophrenia. ... into a tool that can help diagnose the condition. ... of people with schizophrenia is yet to be pinned ...
... medication have long been the cornerstones of managing type ... benefits// these patients. ,Now, a new systematic ... levels, increases the body’s sensitivity to insulin, and decreases ... fat. ,“Type 2 diabetes is an increasing ...
... by Satish K. Pillai, PhD, a staff research associate at ... San Francisco it was found that HIV in the brain ... ,The patients suffered severe to moderate cognitive decline. ... a particular mutation in the HIV envelope gene. The study ...
... pilgrim died of respiratory problems while on a tour ... woman too succumbed// to high-altitude illness while pursuing the ... pilgrim sites in Asia is fast turning into a ... Devi Shriram Bhoyar, a 38-year-old god woman from Maharashtra, ...
... Sandip Datta and Joshua Fierer of the University of ... gamma radiation// killed bacteria are very effective in inducing ... ,The U.S. National Institute of Allergy and Infectious ... said that these bacterial cultures could be used as ...
Cached Medicine News:Health News:FDA Approves New Test For Screening Infection In Babies 2Health News:FDA Approves New Test For Screening Infection In Babies 3Health News:Diagnosing Schizophrenia 2Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 2Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 3Health News:Mutation in the Envelope Gene May Be the Reason for the Development of HIV Linked Cognitive Decline 2Health News:High-altitude Illness Affects Pilgrims of Mansarovar 2